Almirall S.A
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfecti… Read more
Almirall S.A (LBTSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.021x
Based on the latest financial reports, Almirall S.A (LBTSF) has a cash flow conversion efficiency ratio of 0.021x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($31.15 Million) by net assets ($1.46 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Almirall S.A - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Almirall S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Almirall S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Almirall S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aprilbio Co. Ltd.
KQ:397030
|
-0.023x |
|
Shenzhen Newway Photomask Making Co. Ltd. A
SHG:688401
|
N/A |
|
Xiamen Anne Corp Ltd
SHE:002235
|
0.009x |
|
Zhejiang Construction Investment Group Co Ltd
SHE:002761
|
0.044x |
|
Hangzhou Steam Turbine
SHE:200771
|
0.014x |
|
Equitas Small Finance Bank Limited
NSE:EQUITASBNK
|
0.013x |
|
Wereldhave N.V
PINK:WRDEF
|
0.041x |
|
Xinhuanet Co Ltd
SHG:603888
|
0.034x |
Annual Cash Flow Conversion Efficiency for Almirall S.A (2005–2024)
The table below shows the annual cash flow conversion efficiency of Almirall S.A from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.49 Billion | $160.77 Million | 0.108x | +69.08% |
| 2023-12-31 | $1.46 Billion | $93.48 Million | 0.064x | -45.69% |
| 2022-12-31 | $1.32 Billion | $155.10 Million | 0.118x | -35.32% |
| 2021-12-31 | $1.29 Billion | $233.85 Million | 0.182x | +43.80% |
| 2020-12-31 | $1.30 Billion | $164.76 Million | 0.126x | -41.38% |
| 2019-12-31 | $1.28 Billion | $276.15 Million | 0.216x | +79.51% |
| 2018-12-31 | $1.19 Billion | $143.21 Million | 0.120x | +2135.49% |
| 2017-12-31 | $1.13 Billion | $6.09 Million | 0.005x | -92.22% |
| 2016-12-31 | $1.52 Billion | $105.06 Million | 0.069x | -40.86% |
| 2015-12-31 | $1.46 Billion | $170.88 Million | 0.117x | -75.81% |
| 2014-12-31 | $1.34 Billion | $646.93 Million | 0.483x | +539.23% |
| 2013-12-31 | $888.33 Million | $67.11 Million | 0.076x | -38.11% |
| 2012-12-31 | $923.67 Million | $112.75 Million | 0.122x | +4.19% |
| 2011-12-31 | $854.71 Million | $100.14 Million | 0.117x | -45.02% |
| 2010-12-31 | $819.30 Million | $174.60 Million | 0.213x | -38.82% |
| 2009-12-31 | $751.00 Million | $261.60 Million | 0.348x | -- |
| 2008-12-31 | $0.00 | $233.10 Million | x | -- |
| 2007-12-31 | $573.65 Million | $179.03 Million | 0.312x | +45.16% |
| 2006-12-31 | $763.21 Million | $164.09 Million | 0.215x | +36.46% |
| 2005-12-31 | $898.52 Million | $141.57 Million | 0.158x | -- |